Biofluids

Human biofluids refer to bodily fluids such as blood, serum, plasma, urine, saliva, cerebrospinal fluid, and others collected from individuals. They are used in research to study various aspects of health and disease.

Human biofluids contain valuable biomarkers and molecules that can provide insights into health, disease, and therapeutic interventions. They offer a non-invasive or minimally invasive way to access biological information.

Biofluids can be collected through methods like venipuncture (for blood), urine sampling, saliva collection, and lumbar puncture (for cerebrospinal fluid). Proper collection and handling techniques are crucial to maintain sample integrity.

Human biofluids can be used for a wide range of research purposes, including biomarker discovery, disease diagnosis, drug development, epidemiological studies, and monitoring treatment responses.

Biomarkers in biofluids can include proteins, nucleic acids (DNA and RNA), metabolites, hormones, and various other molecules that can indicate the presence of disease or response to treatment.

Researchers should follow strict ethical guidelines and obtain informed consent from donors. Proper safety measures, including handling potentially infectious materials, should be observed.

Biofluid samples are typically stored at low temperatures (e.g., -80°C) to preserve the integrity of the biomolecules within them. Proper labeling and documentation are essential.

Challenges may include sample variability, the need for standardized collection methods, and ethical considerations regarding sample acquisition and consent.

Yes, DNA and RNA can be extracted from biofluids like blood and saliva for genetic research, including genotyping and gene expression analysis.

Yes, privacy and confidentiality are paramount when handling human biofluid samples. Researchers must ensure that donor information is protected and that samples are anonymized or de-identified as necessary.

Yes, biofluid samples can be shared for collaborative research, but this should be done in compliance with ethical and legal regulations and with proper informed consent.

Human biofluids have the potential to play a significant role in personalized medicine by providing insights into an individual’s unique biomolecular profile, helping tailor treatments and interventions.

Obtaining the right human biospecimens can be challenging, especially when a study requires specific disease indications, donor demographics, sample formats, clinical annotations, collection protocols, or geographic diversity. iBioSpecimen helps streamline this process through a broad network of hospitals, laboratories, blood centers, clinics, biobanks, pathology centers, and research partners across the United States, Europe, Asia, and other international regions.

Our global network allows researchers to access a wide variety of human biospecimen types, including clinical remnants, banked samples, prospectively collected specimens, disease-specific samples, and matched sample sets. This flexible sourcing model helps support both small pilot studies and large-scale research or validation programs.

By working with multiple collection partners, iBioSpecimen can assist with biospecimen procurement across different therapeutic areas, including oncology, infectious diseases, autoimmune disorders, cardiovascular diseases, neurological conditions, metabolic disorders, inflammatory diseases, rare diseases, and other clinical indications.

iBioSpecimen can assist with the procurement of multiple types of human biospecimens depending on your research or development needs. These may include:

FFPE tissue blocks and FFPE tissue sections for pathology research, biomarker validation, immunohistochemistry, molecular testing, spatial biology, and companion diagnostic development.

Fresh frozen tissue samples for genomics, transcriptomics, proteomics, biomarker discovery, and molecular research applications.

Human whole blood samples from healthy and diseased donors for genetic research, molecular diagnostics, immune profiling, infectious disease studies, liquid biopsy development, and IVD assay validation.

Plasma and serum samples for biomarker discovery, pharmacokinetic studies, serology testing, proteomics, diagnostic assay development, and clinical research.

PBMCs and immune cell samples for immunology research, cell-based assays, vaccine research, immune profiling, and drug development programs.

Matched biospecimen sets, including matched tissue and blood, matched tumor and normal tissue, matched plasma and serum, matched primary and metastatic tumor samples, and other paired specimen combinations.

Leftover clinical samples and banked specimens for research and development projects where available and ethically permitted.

Prospectively collected human biospecimens based on custom study protocols, disease indications, donor criteria, collection volume, processing requirements, and shipping timelines.

Human biospecimens are widely used across biomedical and clinical research programs. iBioSpecimen supports researchers who require reliable biological samples for applications such as biomarker discovery, oncology research, molecular diagnostics, assay development, IVD validation, companion diagnostic development, drug discovery, translational research, clinical trial support, genetic testing, liquid biopsy studies, immunology research, infectious disease research, and medical device validation.

For oncology research, human biospecimens such as FFPE tissue blocks, tumor tissue sections, plasma, serum, whole blood, and matched tumor-normal samples can support biomarker analysis, mutation testing, IHC validation, FISH testing, NGS assay development, tumor microenvironment studies, and treatment response research.

For molecular diagnostics and IVD development, biospecimens are essential for assay optimization, analytical validation, clinical validation support, sensitivity testing, specificity testing, performance evaluation, and regulatory documentation. iBioSpecimen helps diagnostic companies access relevant human samples according to the requirements of their development and validation programs.

For pharmaceutical and biotech research, disease-specific biospecimens can support drug discovery, target validation, pharmacogenomics, companion diagnostic development, patient stratification, translational medicine, and biomarker-driven clinical research.

iBioSpecimen can assist with sourcing human biospecimens from healthy donors as well as patients with specific disease conditions. Depending on availability and project requirements, disease-specific biospecimens may include oncology samples, infectious disease samples, autoimmune disease samples, inflammatory disease samples, cardiovascular disease samples, metabolic disease samples, neurological disease samples, gastrointestinal disease samples, respiratory disease samples, and rare disease specimens.

Researchers may request samples based on disease type, diagnosis, stage, grade, treatment history, donor demographics, sample format, collection date, preservation method, storage condition, and available clinical data. For pathology-based research, FFPE tissue blocks and tissue sections may be sourced with diagnosis confirmation, tumor percentage, necrosis percentage, tissue site, histological subtype, and other relevant pathology details where available.

FFPE human biospecimens are among the most commonly requested sample types for pathology, oncology, molecular diagnostics, and biomarker research. Formalin-fixed paraffin-embedded tissue blocks and sections are widely used in immunohistochemistry, histology, FISH testing, DNA/RNA extraction, NGS testing, mutation analysis, spatial transcriptomics, and companion diagnostic development.

iBioSpecimen can assist with sourcing FFPE tissue blocks, FFPE tissue scrolls, unstained slides, stained slides, tumor tissue samples, normal tissue samples, matched tumor-normal tissue, primary tumor samples, metastatic tumor samples, and disease-specific FFPE specimens. These samples can support pharmaceutical companies, CROs, diagnostic manufacturers, and academic researchers working on oncology and pathology-based research programs.

Different research applications require different sample formats. Some studies require fresh samples collected within a defined time window, while others may require banked specimens with historical clinical information. iBioSpecimen supports multiple sourcing models depending on the study design.

Fresh human biospecimens may be suitable for cell-based assays, immune profiling, PBMC isolation, RNA-sensitive studies, and applications where sample viability or processing time is important. Frozen biospecimens may be used for molecular research, genomics, proteomics, and biomarker studies. Banked biospecimens may support retrospective studies, assay development, and feasibility testing. Prospective collections may be arranged when a study requires custom donor criteria, collection tubes, processing protocols, storage conditions, or shipment timelines.

Every research project has unique sample requirements. iBioSpecimen supports custom biospecimen procurement based on your specific study protocol. Clients may request samples according to donor age, gender, ethnicity, diagnosis, disease stage, treatment status, sample type, sample volume, anticoagulant type, tissue format, storage condition, processing time, geographic region, and documentation requirements.

For complex projects, iBioSpecimen can help support multi-site sourcing, rare indication searches, matched sample collection, longitudinal sample procurement, and large-volume biospecimen programs. Whether you need a small number of samples for assay feasibility or a larger cohort for validation studies, our team can help identify suitable sourcing options.

When available, human biospecimens may be provided with de-identified clinical data and sample annotations. The level of data depends on sample type, collection site, disease indication, consent permissions, and project scope. Available data may include donor demographics, diagnosis, disease stage, pathology details, treatment information, laboratory values, collection date, storage condition, and relevant clinical history.

Annotated biospecimens are especially valuable for translational research, biomarker discovery, diagnostic validation, drug development, and precision medicine studies. iBioSpecimen helps researchers access samples with relevant supporting information whenever available and ethically permitted.

iBioSpecimen focuses on ethical sourcing, donor privacy, sample traceability, protocol-based collection, and reliable logistics. Human biospecimens are sourced through established clinical and research networks, with attention to documentation, sample handling, collection standards, and research-use requirements.

Our approach is designed to help researchers reduce delays, improve access to required sample types, and support high-quality research outcomes. We understand the importance of sample integrity, donor diversity, traceability, and timely delivery in biomedical research and diagnostic development.

iBioSpecimen works with a wide range of organizations, including pharmaceutical companies, biotechnology firms, CROs, diagnostic manufacturers, medical device companies, academic institutions, clinical researchers, and translational medicine teams. Our biospecimen sourcing services are designed to support early discovery research, assay development, validation studies, clinical research programs, and product development pipelines.

Whether your team is developing a new diagnostic assay, validating an IVD product, studying disease biomarkers, conducting oncology research, building a liquid biopsy platform, or supporting a clinical trial, iBioSpecimen can help source human biospecimens that match your research and development needs.

If you are looking for high-quality human biospecimens for research, iBioSpecimen can help you identify suitable sample options based on your project requirements. Share your required sample type, disease indication, donor criteria, sample quantity, processing requirements, clinical data needs, and shipping destination, and our team will review availability through our global sourcing network.

iBioSpecimen is committed to helping researchers, pharmaceutical companies, biotech firms, CROs, and diagnostic manufacturers access the right human biospecimens for biomedical research, clinical studies, assay development, molecular diagnostics, and medical innovation.